The Discounted Cash Flow (DCF) valuation of SQZ Biotechnologies Co (SQZ) is (78.10) USD. With the latest stock price at 0.44 USD, the upside of SQZ Biotechnologies Co based on DCF is -18054.1%.
Based on the latest price of 0.44 USD and our DCF valuation, SQZ Biotechnologies Co (SQZ) is a sell. selling SQZ stocks now will result in a potential gain of 18054.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 7.7% | 6.5% |
| Long-term Growth Rate | 3.0% - 4.9% | 4.0% |
| Fair Price | (750.89) - (42.57) | (78.10) |
| Upside | -172719.3% - -9886.7% | -18054.1% |